Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial
Titel:
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial
Auteur:
Leroux-Roels, Isabel Prajeeth, Chittappen Kandiyil Aregay, Amare Nair, Niranjana Rimmelzwaan, Guus F Osterhaus, Albert D M E Kardinahl, Simone Pelz, Sabrina Bauer, Stephan D'Onofrio, Valentino Alhatemi, Azhar Jacobs, Bart De Boever, Fien Porrez, Sharon Waerlop, Gwenn Punt, Carine Hendriks, Bart von Mauw, Ellemieke van de Water, Sandra Harders-Westerveen, Jose Rockx, Barry van Keulen, Lucien Kortekaas, Jeroen Leroux-Roels, Geert Wichgers Schreur, Paul J